In Vivo Protection against Retinal Neurodegeneration by Sigma Receptor 1 Ligand (+)-Pentazocine | Zendy

Sylvia B. Smith | Zendy; Jennifer Duplantier | Zendy; Ying Dun | Zendy; Barbara A. Mysona | Zendy; Penny Roon | Zendy; Pamela M. Martin | Zendy; Vadivel Ganapathy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In Vivo Protection against Retinal Neurodegeneration by Sigma Receptor 1 Ligand (+)-Pentazocine

Author(s) -

Sylvia B. Smith,

Jennifer Duplantier,

Ying Dun,

Barbara A. Mysona,

Penny Roon,

Pamela M. Martin,

Vadivel Ganapathy

Publication year - 2008

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.08-1824

Subject(s) - nitrotyrosine , retina , retinal , ganglion cell layer , neurodegeneration , neuroprotection , inner plexiform layer , chemistry , endocrinology , retinal ganglion cell , biology , medicine , microbiology and biotechnology , nitric oxide synthase , pharmacology , nitric oxide , biochemistry , neuroscience , disease

To evaluate the neuroprotective properties of the sigma receptor 1 (sigmaR1) ligand, (+)-pentazocine in an in vivo model of retinal neurodegeneration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research